To the Editor In an Invited Commentary1 accompanying our Original Investigation,2 both published in a recent issue of JAMA Internal Medicine, Villines and Shaw1 emphasize findings that they feel support the National Institute for Health and Care Excellence (NICE) decision to recommend coronary computed tomographic angiography (CCTA) as the initial test for patients with suspected coronary artery disease (CAD). Their argument focuses on the statistically significant reduction in myocardial infarction (MI). We disagree with their interpretation and conclusion.
Foy AJ, Mandrola JM. Disagreement With the NICE Decision. JAMA Intern Med. 2018;178(3):438–439. doi:10.1001/jamainternmed.2017.8661
Customize your JAMA Network experience by selecting one or more topics from the list below.